The Union Cabinet, chaired by Prime Minister Narendra Modi, on 17th July 2019, gave approvals to the Inter-Institutional Agreements between India and USA (United State of America).Cabinet approval

Inter-Institutional Agreement between India and the USA for cooperation in the field of medicine
On July 17, 2019 The Union Cabinet gave its approval to the Inter-Institutional Agreement between India and the USA in the areas of regenerative medicine and 3D(Three-Dimensional) bioprinting, new technologies, exchange of scientific information and technologies, and joint use of scientific infrastructure.

Benefits of MoU:
i. The agreement opens door to all qualified scientists and technologists for joint research projects, training programs, conferences, seminars, etc that will be supported on the basis of scientific merit and excellence.
ii. Both sides will anticipate the general academic exchange regarded under the Agreement will lead to the development of specific projects, each of which may have academic, clinical and commercial implications.

Objective:
The objective of the agreement is to contribute towards the development of research and education through academic collaboration by both the Institutions. The collaboration and exchange of knowledge are intended for both include
i. Exchange of faculty members and students for training, study and research especially in the areas on 3D Bioprinting
ii. Execution of joint research projects
iii. Exchange of information and academic publications.

Background:
In December 2018,  Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, an Institute of National Importance under the Department of Science and Technology (DST), Government of India, signed an agreement on Academic Cooperation with the Wake Forest University Health Sciences on behalf of its Institute for Regenerative Medicine (WFIRM), North Carolina, USA for the cooperation between the two countries in the areas of Science and Technology.

About the USA:
Capital: Washington, D.C.
President: Donald Trump

LEAVE A REPLY

Please enter your comment!
Please enter your name here